A phase II randomized, double-blind, double-dummy, parallel group, placebo controlled study of THR-4109 in obese subjects

Trial Profile

A phase II randomized, double-blind, double-dummy, parallel group, placebo controlled study of THR-4109 in obese subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2012

At a glance

  • Drugs THR 4109 (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jul 2008 Actual completion date July 2008, as reported by ClinicalTrials.gov.
    • 04 Jul 2008 Status changed from in progress to complete as reported by ClinicalTrials.gov.
    • 23 Jan 2008 The expected completion date for this trial is now 1 Jul 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top